Latest News
- Min. Nadda Unveils ?13,000-Crore Bio-Pharma SHAKTI and Chemical Parks Push to Expand India’s Global Chemicals and Biologics Footprint
- Aurobindo Pharma Subsidiary Launches Generic Cancer Drug in US, Expands Oncology Portfolio in Global Generics Market
- KIMS Hospitals Introduces Adaptive Deep Brain Stimulation in India for Advanced Parkinson’s Treatment
Russian pharmaceutical companies cooperate with Algeria
- By Newsdesk
- Russia
- Jun 23, 2023
According to Kira Ivanova, Vice President of R-Pharm, there is great potential for cooperation between Russia and Algeria in the pharmaceutical field. Despite geopolitical implications, Ivanova believes that Algeria is willing to collaborate in this area, as reported by Sputnik Afrique.
During the Russian-Algerian Business Forum held in Moscow on June 14, Ivanova expressed readiness to share expertise, clinical and laboratory research data with Algeria. The aim is to assist Algeria in developing their own skills in pharmaceuticals. Ivanova mentioned that Algeria has been receptive to cooperation and cited the example of the Russian COVID-19 vaccine gaining traction in the Algerian market during the peak of coronavirus information dissemination.
According to Ivanova, the two countries have already established some interaction and mechanisms for aligning regulations, laying the foundation for future pharmaceutical projects. As an illustration, Geropharm, a Russian company, is collaborating with Algeria. In 2023, a local pharmaceutical company in Algeria began producing insulin using Russian technology. The initial batch included 40,000 vials of short-acting genetically engineered human insulin. Production is expected to increase with an additional 80,000 vials by the end of the month. The aim is to provide 50% of the population with locally produced insulin by the end of the year.